{"filings":[{"id":1276397,"accession_number":"0001193125-26-282712","cik":26058,"company_name":"CTS CORP","ticker":"CTS","form_type":"8-K","filed_at":"2026-06-25T20:00:15+00:00","items":["5.02"],"status":"ready","headline":"CTS CEO Kieran O'Sullivan steps down; COO Pratik Trivedi named new CEO effective July 6","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Kieran O'Sullivan transitions from CEO to Executive Chairman effective July 6, 2026.","Pratik Trivedi, formerly COO since Dec 2025, appointed President and CEO effective same date.","Trivedi's base salary $675,000, target cash bonus 100% of salary, LTI award $2.15M (60% PSUs, 40% RSUs).","O'Sullivan as Executive Chairman receives $625,000 base salary, 100% target bonus, no new LTI.","Trivedi also joins Board, increasing size from 8 to 9 directors."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1861970349.5993872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":526479,"accession_number":"0001193125-26-230702","cik":26058,"company_name":"CTS CORP","ticker":"CTS","form_type":"8-K","filed_at":"2026-05-19T20:00:14+00:00","items":["5.07"],"status":"ready","headline":"CTS Corp shareholders elect all eight directors, approve say-on-pay and auditor","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All eight director nominees elected; votes for ranged from 24.6M to 25.6M.","Proposal 2 (non-binding advisory say-on-pay) approved: 25.0M for, 0.7M against.","Proposal 3 (ratification of Grant Thornton as auditor) approved: 26.0M for, 0.5M against.","Annual meeting held May 14, 2026; results filed May 19, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"market_cap_usd":1861970349.5993872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":97838,"accession_number":"0001193125-26-189091","cik":26058,"company_name":"CTS CORP","ticker":"CTS","form_type":"8-K","filed_at":"2026-04-29T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"CTS furnishes April 2026 investor deck; no specific financial updates disclosed","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Company provided investor presentation for meetings with analysts and investors during 2026.","Presentation does not contain earnings results, guidance changes, or material operational updates.","Filing is made under Regulation FD; company makes no admission of materiality of the information."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":1861970349.5993872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":97837,"accession_number":"0001193125-26-189074","cik":26058,"company_name":"CTS CORP","ticker":"CTS","form_type":"8-K","filed_at":"2026-04-29T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"CTS Q1 sales up 11% to $139M; adjusted EPS $0.62; narrows 2026 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Sales $139M, up 11% YoY; diversified end-market sales up 18%, transportation up 3%.","Diluted EPS $0.59 (GAAP) and adjusted diluted EPS $0.62, up from $0.44 in Q1 2025.","Adjusted EBITDA margin 23.0% (up 250 bps); adjusted gross margin 39.5% (up 250 bps).","Net income $17M (12.4% of sales) vs $13M (10.6%) in prior year.","Operating cash flow $17.3M, up from $15.5M; FY guidance: sales $560-580M, adjusted EPS $2.35-2.45."],"consensus_eps_estimate":null,"consensus_eps_actual":0.59,"consensus_revenue_estimate":null,"consensus_revenue_actual":139230000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1861970349.5993872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":112979,"accession_number":"0001193125-26-043742","cik":26058,"company_name":"CTS CORP","ticker":"CTS","form_type":"8-K","filed_at":"2026-02-10T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"CTS Corporation furnishes investor presentation for fiscal 2025","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["Investor presentation for fiscal 2025 furnished as Exhibit 99.1 on Feb 10, 2026","Presentation may be presented at meetings with investors, analysts, and others","Filed by Vice President and CFO Ashish Agrawal on February 10, 2026"],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":1861970349.5993872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":112978,"accession_number":"0001193125-26-043739","cik":26058,"company_name":"CTS CORP","ticker":"CTS","form_type":"8-K","filed_at":"2026-02-10T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"CTS Q4 2025 sales $137M (+9% YoY); EPS $0.67 vs $0.38; FY2026 guide $550-580M sales, $2.30-2.45 adj EPS","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 sales $137M, +9% YoY; diversified markets +16%, transport -1%; net income $20M vs $12M; diluted EPS $0.67 vs $0.38.","Full-year 2025: sales $541M, +5%; net income $65M; diluted EPS $2.19 vs $1.80; adjusted EPS $2.23 vs $2.12.","FY2026 guidance: sales $550-$580M; adjusted diluted EPS $2.30-$2.45.","Adjusted gross margin 39.1% (+150bps); adjusted EBITDA margin 23.7% (+50bps); operating cash flow $29M in Q4.","Diversified end-markets now 57% of revenue, up from 51% in prior year; new business awards strong."],"consensus_eps_estimate":null,"consensus_eps_actual":2.19,"consensus_revenue_estimate":null,"consensus_revenue_actual":541318000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1861970349.5993872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":129382,"accession_number":"0001193125-25-300535","cik":26058,"company_name":"CTS CORP","ticker":"CTS","form_type":"8-K","filed_at":"2025-11-26T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"CTS Senior VP resigns; Pratik Trivedi appointed COO effective Dec 5, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Senior VP Martin Baumeister resigns effective Dec 5, 2025; personal decision to pursue outside opportunity, not due to any disagreement.","Pratik Trivedi, currently Senior VP, appointed COO effective Dec 5, 2025.","Trivedi joined CTS in April 2024; previously VP North America at Eaton (2017-2024) and roles at Cummins.","No material plan, contract, compensation change, or equity grant in connection with Trivedi's COO appointment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":1861970349.5993872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":129381,"accession_number":"0001193125-25-293643","cik":26058,"company_name":"CTS CORP","ticker":"CTS","form_type":"8-K","filed_at":"2025-11-24T23:59:59+00:00","items":["1.01","1.02","2.03","9.01"],"status":"ready","headline":"CTS Corporation enters into $300M unsecured revolving credit facility, replacing prior $400M facility","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["New $300M revolving facility with Wells Fargo as administrative agent; expires November 2025.","Proceeds used to repay $63.3M outstanding under previous $400M credit facility terminated Nov 24, 2025.","Covenants: net leverage ≤ 3.5:1 (4.25:1 for up to four quarters after $100M+ acquisition), interest coverage ≥ 3.0:1.","Incremental capacity up to greater of $125M or 100% EBITDA, subject to pro forma net leverage ≤ 3.0:1."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":1861970349.5993872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":129380,"accession_number":"0001193125-25-268239","cik":26058,"company_name":"CTS CORP","ticker":"CTS","form_type":"8-K","filed_at":"2025-11-06T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"CTS appoints Kimberly Banks MacKay to board, effective Nov 5, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Board expands from 7 to 8 members; MacKay fills newly created vacancy.","MacKay is SVP, General Counsel & Corporate Secretary of West Pharmaceutical Services.","She will serve on Nominating, Governance & Sustainability and Technology & Transactions committees.","Compensation is consistent with other non-employee directors, per prior proxy."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":1861970349.5993872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":129379,"accession_number":"0001193125-25-252840","cik":26058,"company_name":"CTS CORP","ticker":"CTS","form_type":"8-K","filed_at":"2025-10-28T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"CTS furnishes October 2025 investor presentation; no specific financial updates disclosed","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Investor presentation furnished under Item 7.01 Regulation FD; no new financial results or guidance provided.","Presentation may be used in meetings with investors and analysts; content is subject to modifications.","Filed information is not deemed filed for SEC liability purposes and not incorporated by reference."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":1861970349.5993872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":129378,"accession_number":"0001193125-25-252401","cik":26058,"company_name":"CTS CORP","ticker":"CTS","form_type":"8-K","filed_at":"2025-10-28T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"CTS Q3 sales $143M (+8% YoY); diversified end markets +22%, transportation -7%; adjusted EPS $0.60","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Sales $143M, up 8% YoY; diversified end markets +22%, transportation -7%.","GAAP diluted EPS $0.46 vs $0.59; net income $14M includes $4.2M EPA charge.","Adjusted diluted EPS $0.60 vs $0.61; adjusted gross margin 38.9% vs 38.2%.","Updated 2025 guidance: sales $535-$545M, adjusted EPS $2.20-$2.25.","Operating cash flow $29M vs $35M; company cites solid execution and diversification."],"consensus_eps_estimate":null,"consensus_eps_actual":1.52,"consensus_revenue_estimate":null,"consensus_revenue_actual":404047000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1861970349.5993872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":145948,"accession_number":"0000950170-25-098198","cik":26058,"company_name":"CTS CORP","ticker":"CTS","form_type":"8-K","filed_at":"2025-07-24T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"CTS Corporation files investor presentation; no material details disclosed","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Filed on July 24, 2025; presentation for investor and analyst meetings.","Exhibit 99.1 is a July 2025 investor presentation; content unknown.","No specific financial or operational updates are provided in the filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":1861970349.5993872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":145947,"accession_number":"0000950170-25-098145","cik":26058,"company_name":"CTS CORP","ticker":"CTS","form_type":"8-K","filed_at":"2025-07-24T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"CTS Q2 2025: sales up 4% to $135M; diluted EPS $0.62; adjusted EBITDA margin 23.0% vs 21.7%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Sales $135M (+4% YoY); diversified end markets +13%, transportation -6%.","Diluted EPS $0.62 vs $0.48; adjusted diluted EPS $0.57 vs $0.54.","Adjusted EBITDA margin expanded 130 bps to 23.0% from 21.7%.","Operating cash flow $28M vs $20M in Q2 2024.","FY 2025 guidance maintained: sales $520-$550M, adjusted EPS $2.20-$2.35."],"consensus_eps_estimate":null,"consensus_eps_actual":1.06,"consensus_revenue_estimate":null,"consensus_revenue_actual":261078000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1861970349.5993872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":145946,"accession_number":"0000950170-25-092631","cik":26058,"company_name":"CTS CORP","ticker":"CTS","form_type":"8-K","filed_at":"2025-07-02T23:59:59+00:00","items":["5.02","8.01","9.01"],"status":"ready","headline":"CTS appoints Mark Pacioni as Chief Legal & Administrative Officer and Corporate Secretary","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Pacioni effective July 1, 2025; base salary $375,000, target incentive 55% of base.","Receives 4,600 time-based RSUs vesting over 3 years and 7,000 performance-based RSUs tied to financial objectives.","Previously Chief Legal Officer at CareerBuilder + Monster (2019-2025) and held senior legal roles at Boeing, Molex, and Knowles.","CEO Kieran O'Sullivan cites Pacioni's broad experience as strong contributor to global strategy and business diversification."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1861970349.5993872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":164244,"accession_number":"0000950170-25-068809","cik":26058,"company_name":"CTS CORP","ticker":"CTS","form_type":"8-K","filed_at":"2025-05-12T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"CTS shareholders elect all seven director nominees, approve advisory say-on-pay and auditor ratification","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All seven director nominees elected: Donna Costello, Amy Dodrill, William Johnson, Kieran O'Sullivan, Robert Profusek, Randy Stone, Alfonso Zulueta.","Advisory vote on executive compensation approved: 26.4M for, 829K against.","Ratification of Grant Thornton as independent auditor for FY2025 approved: 27.6M for, 511K against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.0,"calibrated_materiality_score":0.0,"market_cap_usd":1861970349.5993872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":164243,"accession_number":"0000950170-25-060591","cik":26058,"company_name":"CTS CORP","ticker":"CTS","form_type":"8-K","filed_at":"2025-04-30T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"CTS Corporation files April 2025 investor presentation with no disclosed material updates","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Investor presentation furnished under Item 7.01; content not detailed in filing excerpt.","No specific financial guidance, transaction, or management changes cited.","Presentation may be used at meetings during fiscal year 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"market_cap_usd":1861970349.5993872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":164242,"accession_number":"0000950170-25-060587","cik":26058,"company_name":"CTS CORP","ticker":"CTS","form_type":"8-K","filed_at":"2025-04-30T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"CTS Q1 EPS $0.44 vs $0.36 YoY; sales flat at $126M; diversified +14%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Sales $126M flat YoY; diversified end-markets +14%, transportation -12%; SyQwest added $3M.","Net income $13M (11% of sales) vs $11M (9%); diluted EPS $0.44 vs $0.36.","Adjusted diluted EPS $0.44 vs $0.47; adjusted EBITDA margin 20.5% vs 20.3%.","Operating cash flow $16M vs $18M in Q1 2024.","Maintains FY2025 guidance: sales $520-$550M; adjusted diluted EPS $2.20-$2.35."],"consensus_eps_estimate":null,"consensus_eps_actual":0.44,"consensus_revenue_estimate":null,"consensus_revenue_actual":125769000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1861970349.5993872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":182017,"accession_number":"0000950170-25-036408","cik":26058,"company_name":"CTS CORP","ticker":"CTS","form_type":"8-K","filed_at":"2025-03-10T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"CTS Corp. Chief Legal Officer Scott D'Angelo resigns, effective April 4, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Scott D'Angelo announced resignation as VP, Chief Legal & Admin Officer and Corporate Secretary.","Resignation effective April 4, 2025; D'Angelo will stay in role until that date.","Resignation is personal to pursue another chief legal officer role, not due to any disagreement.","No successor has been named in the filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":1861970349.5993872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":182016,"accession_number":"0000950170-25-013005","cik":26058,"company_name":"CTS CORP","ticker":"CTS","form_type":"8-K","filed_at":"2025-02-04T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"CTS files routine investor presentation; content not available for review","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Exhibit 99.1 is an investor presentation dated February 2025, for use in meetings during fiscal 2025.","The filing does not contain any specific financial updates or material changes.","No new guidance, earnings, or strategic announcements are evident from the provided text.","The presentation content was not included in full, preventing detailed analysis."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":1861970349.5993872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":182015,"accession_number":"0000950170-25-012851","cik":26058,"company_name":"CTS CORP","ticker":"CTS","form_type":"8-K","filed_at":"2025-02-04T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"CTS Q4 sales $127M (+2% YoY); adjusted EPS $0.53; FY 2025 guidance $520-550M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 sales $127M, up 2% YoY; diversified end-markets +28%, transportation -18%.","Q4 adjusted diluted EPS $0.53 vs $0.47; GAAP EPS $0.45 vs $0.49.","Full-year sales $516M (-6% YoY); net income $58M; adjusted diluted EPS $2.17 vs $2.22.","2025 guidance: sales $520-550M, adjusted diluted EPS $2.20-$2.35.","SyQwest acquisition added $14M revenue in 2024; diversified markets now >50% of revenue."],"consensus_eps_estimate":null,"consensus_eps_actual":1.89,"consensus_revenue_estimate":null,"consensus_revenue_actual":515771000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1861970349.5993872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":198676,"accession_number":"0000950170-24-118150","cik":26058,"company_name":"CTS CORP","ticker":"CTS","form_type":"8-K","filed_at":"2024-10-29T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"CTS files 8-K to furnish investor presentation; no specific disclosures","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["No financial or operational figures reported; only presentation title 'CTS Investor Presentation October 2024'.","Filing is a routine Regulation FD disclosure with no material new information for investors.","No earnings, guidance, or operational updates were included in this filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":1861970349.5993872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":198675,"accession_number":"0000950170-24-117947","cik":26058,"company_name":"CTS CORP","ticker":"CTS","form_type":"8-K","filed_at":"2024-10-29T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"CTS Q3 net income $19M, sales $132M; lowers FY sales guidance to $515-525M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Sales $132M, down 2% YoY; net income $19M ($0.61 diluted EPS) vs $14M ($0.44) in Q3 2023.","Adjusted EPS $0.63, up from $0.54; adjusted EBITDA margin 24.8% vs 22.5% YoY.","Diversified end markets +18% YoY; transport -17% YoY; sequential sales +2%.","Operating cash flow $35M, up from $22M in Q3 2023.","FY2024 sales guidance reduced to $515-525M (prior $525-540M); adjusted EPS reiterated $2.05-$2.25."],"consensus_eps_estimate":null,"consensus_eps_actual":1.45,"consensus_revenue_estimate":null,"consensus_revenue_actual":388336000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1861970349.5993872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":214705,"accession_number":"0000950170-24-104989","cik":26058,"company_name":"CTS CORP","ticker":"CTS","form_type":"8-K","filed_at":"2024-09-10T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"CTS Corp principal accounting officer Thomas White resigns; CFO Agrawal to succeed","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Thomas White resigns as principal accounting officer effective September 18, 2024.","White leaves to pursue a new professional opportunity, not due to any accounting disagreement.","CFO Ashish Agrawal will assume the role of principal accounting officer upon White's departure.","No change in financial reporting or internal controls anticipated."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":1861970349.5993872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":214704,"accession_number":"0000950170-24-087817","cik":26058,"company_name":"CTS CORP","ticker":"CTS","form_type":"8-K","filed_at":"2024-07-30T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"CTS Corporation files investor presentation for July 2024 meetings; no specific financial updates disclosed.","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Furnished investor presentation dated July 2024 for meetings with investors and analysts.","Presentation provided under Regulation FD; no admission of materiality is made.","No quantitative or material business changes were explicitly disclosed in the filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":1861970349.5993872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":214703,"accession_number":"0000950170-24-087512","cik":26058,"company_name":"CTS CORP","ticker":"CTS","form_type":"8-K","filed_at":"2024-07-30T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"CTS Q2 sales $130M (-10% YoY); acquires SyQwest for $125M; updates FY guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 sales $130M, down 10% YoY; net income $15M, diluted EPS $0.48; adjusted EPS $0.54.","Adjusted EBITDA margin 21.7% (up from 21.3% YoY); operating cash flow $20M (down from $23M).","Non-transportation sales up 11% sequentially and 4% YoY; transportation sales down 22% YoY.","Acquired SyQwest (sonar/acoustic sensing for naval defense) on July 29 for $125M net, enhancing defense capabilities.","Updated FY2024 guidance: sales $525-$540M, adjusted diluted EPS $2.05-$2.25, citing moderate growth expectations."],"consensus_eps_estimate":null,"consensus_eps_actual":0.84,"consensus_revenue_estimate":null,"consensus_revenue_actual":255912000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":1861970349.5993872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":233839,"accession_number":"0000950170-24-058777","cik":26058,"company_name":"CTS CORP","ticker":"CTS","form_type":"8-K","filed_at":"2024-05-13T23:59:59+00:00","items":["5.03","5.07","9.01"],"status":"ready","headline":"CTS shareholders elect seven directors, approve say-on-pay, ratify auditor","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All director nominees elected; votes for ranged from 25.8M to 28.3M, with 799,741 broker non-votes.","Non-binding advisory vote on executive compensation approved: 27.6M for, 725,697 against, 19,018 abstentions.","Ratification of Grant Thornton as independent auditor for FY2024: 28.76M for, 411,876 against, 10,597 abstentions.","Bylaws amended ministerially to remove annual board meeting reference and clarify corporate secretary duties."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":1861970349.5993872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":233838,"accession_number":"0000950170-24-051206","cik":26058,"company_name":"CTS CORP","ticker":"CTS","form_type":"8-K","filed_at":"2024-05-01T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"CTS furnishes May 2024 investor presentation; no financial details provided in filing","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Presentation was furnished under Item 7.01 as Exhibit 99.1 for use in investor meetings.","No specific financial figures, guidance updates, or material news were disclosed in the filing text.","Company trades on NYSE under symbol CTS; presentation content remains unavailable for review.","Filing is routine Regulation FD disclosure with no material operational or financial metrics."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":1861970349.5993872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":233837,"accession_number":"0000950170-24-050908","cik":26058,"company_name":"CTS CORP","ticker":"CTS","form_type":"8-K","filed_at":"2024-05-01T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"CTS Q1 sales fall 14% YoY to $125.7M; EPS drops to $0.36 from $0.58","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 sales $125.7M, down 14% YoY; non-transportation -17%, transportation -10%.","Net income $11M ($0.36 diluted EPS) vs. $18M ($0.58) in Q1 2023.","Adjusted EPS $0.47 (down from $0.61); adjusted EBITDA margin 20.3% (down from 21.9%).","Operating cash flow improved to $18M from $11M in prior-year quarter.","FY 2024 guidance reaffirmed: sales $530-570M, adjusted EPS $2.10-2.35."],"consensus_eps_estimate":null,"consensus_eps_actual":0.36,"consensus_revenue_estimate":null,"consensus_revenue_actual":125750000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1861970349.5993872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":251821,"accession_number":"0000950170-24-012847","cik":26058,"company_name":"CTS CORP","ticker":"CTS","form_type":"8-K","filed_at":"2024-02-08T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"CTS appoints Amy M. Dodrill to board of directors, effective Feb 8","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Board expanded from six to seven members; Dodrill fills the vacancy.","Dodrill most recently President of Baxter's $2B Global Surgical Solutions and Patient Support Systems segment.","She also serves on Procept BioRobotics (PRCT) board, on audit and compensation committees.","Dodrill appointed to nominating, governance and sustainability and technology and transactions committees."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":1861970349.5993872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":251820,"accession_number":"0000950170-24-011691","cik":26058,"company_name":"CTS CORP","ticker":"CTS","form_type":"8-K","filed_at":"2024-02-06T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"CTS Corporation furnishes February 2024 investor presentation, no specific financial data provided in filing.","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Filed under Item 7.01 Regulation FD; presentation may be used in future investor meetings.","No material new financial or operational information disclosed in the 8-K itself.","Presentation content not included in filing; unable to assess specific statements.","Company makes no admission as to materiality of information per Regulation FD."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":1861970349.5993872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":251819,"accession_number":"0000950170-24-011541","cik":26058,"company_name":"CTS CORP","ticker":"CTS","form_type":"8-K","filed_at":"2024-02-06T23:59:59+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"CTS Q4 sales down 12% to $125M; adj. EPS $0.47; launches $100M buyback","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 sales $125M (-12% YoY); net income $15M; diluted EPS $0.49; adjusted diluted EPS $0.47.","FY2023 sales $550M (-6% YoY); adj. diluted EPS $2.22 (down from $2.46); adj. EBITDA margin 22%.","2024 guidance: sales $530-$570M; adj. diluted EPS $2.10-$2.35; expects soft H1, improving H2.","Board approved $100M share repurchase program, replacing prior program with no expiration date."],"consensus_eps_estimate":null,"consensus_eps_actual":1.92,"consensus_revenue_estimate":null,"consensus_revenue_actual":550422000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1861970349.5993872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":269352,"accession_number":"0000950170-23-055591","cik":26058,"company_name":"CTS CORP","ticker":"CTS","form_type":"8-K","filed_at":"2023-10-26T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"CTS Corporation furnishes investor presentation for October 2023; no material new details provided","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Presentation may be used at meetings with investors and analysts during fiscal 2023.","No specific financial results, guidance, or strategic announcements are disclosed in the filing or exhibit.","Information is furnished under Regulation FD and is not filed or incorporated by reference into SEC reports."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":1861970349.5993872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":269351,"accession_number":"0000950170-23-055368","cik":26058,"company_name":"CTS CORP","ticker":"CTS","form_type":"8-K","filed_at":"2023-10-26T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"CTS Q3 sales down 11% to $135M; adjusted EPS $0.54; cuts full-year guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Sales: $135M, down 11% YoY; non-transportation down 20%, transportation down 3%.","Net income $14M (10.4% of sales) vs $12M (7.8%) YoY; diluted EPS $0.44 vs $0.37.","Adjusted diluted EPS $0.54, down from $0.62; adjusted EBITDA margin 22.5%.","Updated FY2023 guidance: sales $545-555M (prev $565-585M), adj diluted EPS $2.15-2.25 (prev $2.20-2.40).","Operating cash flow $22M vs $60M (prior year included $34M one-time pension inflow)."],"consensus_eps_estimate":null,"consensus_eps_actual":1.43,"consensus_revenue_estimate":null,"consensus_revenue_actual":425728000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1861970349.5993872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":286333,"accession_number":"0000950170-23-034396","cik":26058,"company_name":"CTS CORP","ticker":"CTS","form_type":"8-K","filed_at":"2023-07-25T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"CTS Corp furnishes investor presentation for July 2023; no specific financial targets disclosed in exhibit","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Exhibit 99.1 is an investor presentation dated July 2023, but its content is not reproduced in the filing.","Presentation may be used in meetings with investors and analysts; no material facts available.","This filing is a routine Regulation FD disclosure without admission of materiality."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":1861970349.5993872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":286332,"accession_number":"0000950170-23-034232","cik":26058,"company_name":"CTS CORP","ticker":"CTS","form_type":"8-K","filed_at":"2023-07-25T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"CTS Q2 sales flat YoY at $145.2M, net income $12.9M; cuts full-year guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 sales $145.2M (+0.1% YoY); transportation up 10%, non-transportation down 10%.","Adjusted diluted EPS $0.59 vs $0.62; adjusted EBITDA margin 21.3% vs 22.4%.","Full-year 2023 guidance lowered: sales now $565-$585M (was $580-$640M), adjusted EPS $2.20-$2.40.","Operating cash flow improved to $23.4M from $16.1M; first eBrake award and EV platform wins cited.","CEO cites continued softness in distribution and industrial end market."],"consensus_eps_estimate":null,"consensus_eps_actual":0.98,"consensus_revenue_estimate":null,"consensus_revenue_actual":291176000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1861970349.5993872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":306176,"accession_number":"0000950170-23-022215","cik":26058,"company_name":"CTS CORP","ticker":"CTS","form_type":"8-K","filed_at":"2023-05-15T23:59:59+00:00","items":["5.03","5.07","9.01"],"status":"ready","headline":"CTS Corp. amends bylaws for electronic board consents and holds 2023 annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board amended Article VIII of bylaws to permit electronic board consents under Indiana law.","All six director nominees elected: Donna Costello, William Johnson, Kieran O'Sullivan, Robert Profusek, Randy Stone, Alfonso Zulueta.","Non-binding advisory vote on executive compensation (say-on-pay) approved with 27,851,669 for vs 980,524 against.","Shareholders favored one-year frequency for future say-on-pay votes; board adopted annual frequency.","Shareholder proposal to require shareholder approval for termination pay failed with 14,025,960 for vs 14,802,616 against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":1861970349.5993872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":306175,"accession_number":"0000950170-23-015268","cik":26058,"company_name":"CTS CORP","ticker":"CTS","form_type":"8-K","filed_at":"2023-04-27T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"CTS files investor presentation for April 2023; no new material data disclosed in filing text","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Company furnished investor presentation under Item 7.01 Regulation FD.","Presentation may be used at meetings with investors and analysts during fiscal 2023.","No specific financial results, guidance, or material updates were included in the filing body."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":1861970349.5993872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":306174,"accession_number":"0000950170-23-015010","cik":26058,"company_name":"CTS CORP","ticker":"CTS","form_type":"8-K","filed_at":"2023-04-27T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"CTS Q1 sales $146M (-1.2% YoY); adj. EPS $0.61 down 9%; maintains FY guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Sales $146.0M, down 1.2% YoY; non-transportation up 4.6%, transportation down 6.1%.","Net income $18.3M (12.6% of sales) vs $20.2M (13.7%) in Q1 2022.","Adjusted diluted EPS $0.61, down from $0.67; GAAP EPS $0.58 vs $0.63.","Adjusted EBITDA margin 21.9% vs 23.5%; operating cash flow $11.2M vs $19.3M.","FY 2023 guidance maintained: sales $580-$640M, adjusted diluted EPS $2.40-$2.70."],"consensus_eps_estimate":null,"consensus_eps_actual":0.58,"consensus_revenue_estimate":null,"consensus_revenue_actual":145994000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1861970349.5993872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":325362,"accession_number":"0000950170-23-008637","cik":26058,"company_name":"CTS CORP","ticker":"CTS","form_type":"8-K","filed_at":"2023-03-17T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Director Ye Jane Li will not stand for re-election at CTS 2023 annual meeting","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Ye Jane Li informed CTS she will not stand for re-election to the Board at the May 11, 2023 annual meeting.","Her decision is not due to any disagreement with the company on operations, policies, or practices.","The company thanked Ms. Li for her service."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":1861970349.5993872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":325361,"accession_number":"0000950170-23-002491","cik":26058,"company_name":"CTS CORP","ticker":"CTS","form_type":"8-K","filed_at":"2023-02-10T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"CTS Corp authorizes $50M share repurchase program, replacing May 2021 plan","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board approved repurchase of up to $50M of common stock, replacing May 2021 authorization.","Program has no set expiration date; repurchases may be made in open market or privately.","Company not obligated to repurchase any amount; program may be suspended or terminated at any time."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":1861970349.5993872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":325360,"accession_number":"0000950170-23-002394","cik":26058,"company_name":"CTS CORP","ticker":"CTS","form_type":"8-K","filed_at":"2023-02-09T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"CTS Corporation appoints Randy Stone to board of directors effective Feb 9, 2023","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Randy Stone elected as director effective February 9, 2023.","Stone most recently served as President of DuPont’s Mobility & Materials segment.","He will serve on the Nominating, Governance and Sustainability and Technology and Transactions Committees."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":1861970349.5993872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":325359,"accession_number":"0000950170-23-001987","cik":26058,"company_name":"CTS CORP","ticker":"CTS","form_type":"8-K","filed_at":"2023-02-07T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"CTS posts investor presentation for Feb 2023; no new financial data in filing","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Presentation may be used at meetings with investors and analysts during fiscal 2023.","No specific financial results or material business updates were included in the 8-K body.","Exhibit 99.1 titled 'CTS Investor Presentation Feb 2023' was furnished but not filed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":1861970349.5993872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":325358,"accession_number":"0000950170-23-001917","cik":26058,"company_name":"CTS CORP","ticker":"CTS","form_type":"8-K","filed_at":"2023-02-07T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"CTS Q4 sales up 7% to $142.3M, adjusted EPS $0.56; guides FY2023 sales $580-640M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Fourth-quarter revenue $142.3M (+7% YoY); non-transportation sales up 22%.","Adjusted diluted EPS $0.56 (Q4 2021: $0.49); GAAP EPS $0.47 (Q4 2021: $0.28).","Full-year 2022 revenue $586.9M (+14%), adjusted diluted EPS $2.46 (2021: $1.93).","Adjusted EBITDA margin 22.8% for 2022 vs 21.0% in 2021.","2023 guidance: revenue $580-640M, adjusted diluted EPS $2.40-2.70."],"consensus_eps_estimate":null,"consensus_eps_actual":1.85,"consensus_revenue_estimate":null,"consensus_revenue_actual":586869000.0,"consensus_period":"2022-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1861970349.5993872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":343123,"accession_number":"0000950170-22-025622","cik":26058,"company_name":"CTS CORP","ticker":"CTS","form_type":"8-K","filed_at":"2022-11-22T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"CTS adopts majority voting standard for director elections and updates bylaws for universal proxy","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Shareholders approved amendment to Articles of Incorporation for majority voting standard in uncontested director elections.","Board approved amendments to Bylaws to reflect majority voting standard and to address Rule 14a-19 universal proxy requirements.","Amended and Restated Bylaws filed as Exhibit 3.1 effective as of November 10, 2022.","Changes approved at 2022 Annual Meeting held on November 10, 2022."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":1861970349.5993872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":343122,"accession_number":"0000950170-22-020164","cik":26058,"company_name":"CTS CORP","ticker":"CTS","form_type":"8-K","filed_at":"2022-10-26T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"CTS Corporation files investor presentation; no specific new details provided in filing","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Filing furnishes an investor presentation dated October 2022 under Regulation FD.","No financial results, guidance, or material updates are extractable from the presented text.","Presentation is intended for use in meetings with investors and analysts during fiscal 2022."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"market_cap_usd":1861970349.5993872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":343121,"accession_number":"0000950170-22-020108","cik":26058,"company_name":"CTS CORP","ticker":"CTS","form_type":"8-K","filed_at":"2022-10-26T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"CTS Q3 revenue up 24% to $151.9M; adjusted EPS $0.62 vs $0.46","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Sales $151.9M (+24% YoY); net income $11.8M vs $63.9M net loss in Q3 2021.","Adjusted diluted EPS $0.62, up from $0.46; Adjusted EBITDA margin 22.3% vs 21.7%.","FY2022 sales guidance raised to $585-595M; adjusted EPS guidance unchanged at $2.40-2.55.","Operating cash flow $60.4M, including $34M from pension termination; non-transport sales +22.5%."],"consensus_eps_estimate":null,"consensus_eps_actual":1.38,"consensus_revenue_estimate":null,"consensus_revenue_actual":444588000.0,"consensus_period":"2022-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":1861970349.5993872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":359676,"accession_number":"0000950170-22-019050","cik":26058,"company_name":"CTS CORP","ticker":"CTS","form_type":"8-K","filed_at":"2022-09-29T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Gordon Hunter resigns from CTS Corporation Board on September 23, 2022","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Gordon Hunter resigned from the CTS Board effective September 23, 2022.","Resignation was not due to any disagreement with the company's operations, policies, or practices.","CTS thanked Mr. Hunter for his service and contributions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":1861970349.5993872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":359675,"accession_number":"0000950170-22-013106","cik":26058,"company_name":"CTS CORP","ticker":"CTS","form_type":"8-K","filed_at":"2022-07-26T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"CTS furnishes July 2022 investor presentation; no material updates disclosed","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Presentation furnished for meetings with investors, analysts, and others during FY 2022.","No specific financial results, guidance, or operational metrics included in the filing.","Presentation content not provided; unable to extract material changes or new information."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":1861970349.5993872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":359674,"accession_number":"0000950170-22-013038","cik":26058,"company_name":"CTS CORP","ticker":"CTS","form_type":"8-K","filed_at":"2022-07-26T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"CTS Q2 sales up 12% to $145M, adj. EPS $0.62; raises FY2022 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 sales $145M (+12% YoY); net income $12.6M ($0.39 diluted) vs $0.9M a year ago.","Adjusted diluted EPS $0.62, up from $0.52; Adj. EBITDA margin 22.4% (+90 bps).","Raises FY2022 guidance: sales $570-600M, adj. EPS $2.40-2.55 (prev $2.20-2.45).","Non-transportation sales grew 21%, transportation up 4%; Ferroperm acquisition contributed.","Operating cash flow $16.1M, down from $18.7M due to FX impact."],"consensus_eps_estimate":null,"consensus_eps_actual":1.02,"consensus_revenue_estimate":null,"consensus_revenue_actual":292677000.0,"consensus_period":"2022-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":1861970349.5993872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":359673,"accession_number":"0001564590-22-025088","cik":26058,"company_name":"CTS CORP","ticker":"CTS","form_type":"8-K","filed_at":"2022-07-01T23:59:59+00:00","items":["8.01","7.01","9.01"],"status":"ready","headline":"CTS completes acquisition of Ferroperm Piezoceramics for ~$74M (DKK 525M)","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquisition closed on June 30, 2022; purchase price of DKK 525M (~$74M at 7.09 DKK/USD).","Ferroperm is a leading supplier of high-performance piezoceramic components for medical, industrial, and aerospace.","CEO Kieran O'Sullivan says deal advances diversification strategy and is expected to be accretive in 2023.","Ferroperm's European base and medical therapeutic experience complement CTS's capabilities."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1861970349.5993872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2022-07-01T23:59:59+00:00|359673"}